Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwabe-Wenex International operates as a regional affiliate of the global Schwabe Group. The company focuses on commercializing clinically tested herbal medicines and homeopathic products across Asia-Pacific markets. Its parent group has a long history of clinical research supporting efficacy for key products such as Tebonin® (Ginkgo biloba) for cognitive impairment and Crataegutt® novo for heart performance. The group’s portfolio includes several well-established brands with proven safety profiles in large-scale post-marketing use[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwabe-Wenex International.